Adrenal Crisis Therapies
Adrenal Crisis Market

Adrenal Crisis


An Adrenal Crisis is a medical emergency that can cause life-threatening complications such as shock or kidney failure if not treated. A crisis is usually set off when affected individuals are under stress during an accident, trauma, surgery, or severe infection.

An Adrenal Crisis is characterized by an acute change in physiologic status, quickly progression from nonspecific symptoms of fatigue, weakness, nausea, vomiting, abdominal pain, back pain, diarrhea, dizziness, hypotension, syncope, eventually to obtundation, metabolic encephalopathy, and shock.


Adrenal Crisis Epidemiology Segmentation in the 7MM


  • Total Prevalent Cases of Adrenal Crisis
  • Age-specific Cases of Adrenal Crisis
  • Gender-specific Cases of Adrenal Crisis


Adrenal Crisis Epidemiological Insights Observed in the 7MM (2021)


  • The total prevalent population of Adrenal Crisis in the 7MM was estimated to be 130K cases.
  • The total prevalent population of Adrenal Crisis in the US was found to be 53.2K cases.
  • The total prevalent population of Adrenal Crisis in Germany was 14.7K cases.
  • The total diagnosed prevalent population of Adrenal Crisis in Spain was observed to be 8.2K cases.


Adrenal Crisis Market Insight


The market size of the Adrenal Crisis in the 7MM was found to be approximately USD 11.5 million in the year 2021.  


Adrenal Crisis Emerging Drugs


The emerging drugs in the Adrenal Crisis market are


  • ATRS-1902
  • Zeneo, and many others


Adrenal Crisis Key Players 


The key players working in the Adrenal Crisis market are


  • Antares Pharma
  • Eton Pharmaceuticals, and several others